Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
ARCH Venture Partners is an early-stage VC focused on life science discoveries. Founded 1986 in Chicago.
Focuses on life science discoveries to prevent, detect, and cure disease. Bridges academic research with commercial biotech.
Among the most prolific life sciences venture investors. Strong university research bridge.
To approach ARCH Venture Partners, founders should prepare a clear and compelling pitch that highlights their innovative solutions in the life sciences. Interested parties can submit their pitches through the contact page at archventure.com/contact.
In the past year, ARCH Venture Partners has made 10 investments, including notable companies such as Agios Pharmaceuticals and GRAIL, showcasing their commitment to addressing significant medical challenges.
ARCH Venture Partners invests in Seed, Series A, and Series B stages.
ARCH focuses on biotech and healthcare sectors, particularly life science discoveries.
The firm typically invests between $2 million and $20 million.
ARCH primarily invests in North America.
You can pitch ARCH by visiting their contact page at archventure.com/contact.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.